Upon manipulating the expression of pathway-associated genes in tumor cells and co-cultivating them with CD8+ T cells, we observed that downregulating PITPNC1 and FASN led to an increased proportion of IFN-γ+ CD8+ T cells, along with heightened cytotoxic effects against tumor cells. The gene discussed is CD8A; the disease is neoplasm.